About Us: At ABK Biomedical, based in Halifax, Nova Scotia, we’re transforming interventional radiology through the development of proprietary embolization technologies that enhance the treatment of hypervascular tumors and improve patient outcomes. Led by a seasoned leadership team, backed by $30M in recent Series B funding, and driven by a talented group of scientists, engineers and support personnel, we’re poised to commercialize our novel radiopaque microspheres technology throughout multiple markets.